Company Search:
Advanced Search
Sponsored Links
Quidel Corporation Company Snapshot
Quidel Corporation operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Quidel with three other companies in this sector in the United States: Trinity Biotech PLC (2016 sales of $99.61 million of which 74% was Clinical Laboratory), Neogen Corporation ($321.28 million of which 55% was Animal Safety), and Meridian Bioscience, Inc. ($196.08 million of which 74% was US Diagnostics).

Sales Analysis. Quidel reported sales of $191.60 million for the year ending December of 2016. This represents a decrease of 2.3% versus 2015, when the company's sales were $196.13 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Quidel Corporation
  Stock Performance Chart for Quidel Corporation
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 45.99
(Figures in U.S. Dollars)
1 Week -1.9%   13 Weeks 15.0%  
4 Weeks 7.3%   52 Weeks 130.8%  
Quidel Corporation Key Data:
  Ticker: QDEL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 191,603,000
(Year Ending Jan 2017).
Employees: 627
  Currency: U.S. Dollars Market Cap: 1,563,517,017
  Fiscal Yr Ends: December Shares Outstanding: 33,996,891
  Share Type: Common Closely Held Shares: 5,789,876
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.